Start 30 days free, no card. Full Pro access for a month, then decide. Start free

Back to analysts list

Analyst

Albert Rice

UBS · covers Healthcare

Period: Reporting period mapped to calendar 2026 Q1.

Limited coverage. Only 2 questions of coverage. Treat these numbers as directional — sample too small for reliable averages.
Questions
2on tracked calls
Challenge rate
0%none of 2 questionsLimited sample
Companies
1questioned at least once
Reporting periods
1with questions

These figures cover the whole profile: every tracked question, all reporting periods.

How to read these numbers

Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.

Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.

No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.

Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.

Small samples. Profiles with fewer than 10 questions are marked Limited sample.

Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.

Questions asked

Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.

Showing 2 of 2 questions from 1 company

HCAHCA Healthcare2 questions · 1 reporting period · 0 of 2 challenging
HCA company page →

Calendar 2026 Q1

the right way -- am I hearing you say, you basically had $180 million of negative impact from flu and weather in the first quarter

DemandRevenue GrowthTranscript · FY2026 Q1 →
Show response

Mike confirmed the analyst's math was generally in the zone and emphasized temporal nature of the shortfall.

update us on where you're at with the AI initiatives? And is that $400 million a pretty firm number

Innovation & R&DCost PressureTranscript · FY2026 Q1 →
Show response

Sam detailed AI rollout progress including ambient listening, nurse handoff, and case management, expressing confidence in the $400M target.

Challenge rate by company

Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.

CompanyQuestionsChallenge rate
HCA HCA Healthcare2—Rate withheld: fewer than 3 questions
  • HCA
    HCA Healthcare · 2 questions
    —rate withheld: under 3 questions

Activity by reporting period

Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.

Questions by calendar reporting period
Calendar periodQuestionsChallenge rateCompanies
2026 Q120%none of 2 questions1
  1. 2026 Q12 questions · challenge rate 0% (none of 2 questions) · 1 company

Topics

Topics tagged on this analyst’s questions.

  • Demand1
  • Revenue Growth1
  • Innovation & R&D1
  • Cost Pressure1